Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) EBITDA Margin (2021 - 2025)

Historic EBITDA Margin for Pulse Biosciences (PLSE) over the last 3 years, with Q3 2025 value amounting to 22540.7%.

  • Pulse Biosciences' EBITDA Margin changed N/A to 22540.7% in Q3 2025 from the same period last year, while for Sep 2025 it was 86898.84%, marking a year-over-year change of. This contributed to the annual value of 8357.86% for FY2022, which is 38685100.0% down from last year.
  • Latest data reveals that Pulse Biosciences reported EBITDA Margin of 22540.7% as of Q3 2025.
  • Pulse Biosciences' EBITDA Margin's 5-year high stood at 102188.89% during Q4 2022, with a 5-year trough of 22540.7% in Q3 2025.
  • Its 3-year average for EBITDA Margin is 10761.35%, with a median of 2157.35% in 2021.
  • Over the last 5 years, Pulse Biosciences' EBITDA Margin had its largest YoY gain of 1040154300bps in 2022, and its largest YoY loss of -202394400bps in 2022.
  • Over the past 3 years, Pulse Biosciences' EBITDA Margin (Quarter) stood at 1826.54% in 2021, then soared by 5695bps to 102188.89% in 2022, then crashed by -122bps to 22540.7% in 2025.
  • Its EBITDA Margin was 22540.7% in Q3 2025, compared to 102188.89% in Q4 2022 and 4665.33% in Q2 2022.